Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Discovery-Driven Plasma Proteomics Identifies a Multi-Protein Signature for Amyloid PET Positivity: A Machine Learning Analysis of the Bio-Hermes Cohort.

International journal of molecular sciences·2026
Same author

Associations of plasma biomarkers of Alzheimer's disease pathology with modifiable risk factors and cognitive and functional outcomes: evidence from cross-sectional prediction and latent path analyses in the Bio-Hermes-001 cohort.

Alzheimer's research & therapy·2026
Same author

Dementia data for people living in care homes: cross-sectoral national data linkage study of care home, healthcare and administrative data sources.

International journal of population data science·2026
Same author

Information leaflets vs artificial intelligence: comparing perceptions of stroke survivors and professionals in a mixed-methods study.

European stroke journal·2026
Same author

Modernising functional independence measurement: Validation of a Contemporary Extended Activities of Daily Living scale in a mixed sample.

Clinical rehabilitation·2026

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Kalliopi Mavromati1

  • 1University of Glasgow, Glasgow, Scotland, United Kingdom.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 25, 2025
PubMed
Summary

The Scottish Data Challenge democratized access to Alzheimer's Disease (AD) individual participant data (IPD), fostering global research collaboration and innovation in dementia research.

Area of Science:

  • Neuroscience
  • Data Science
  • Public Health

Background:

  • Individual participant data (IPD) access is often restricted, limiting research.
  • The Scottish Data Challenge aimed to democratize data access through a collaborative initiative.
  • Partnerships included the Scottish Brain Health Alliance, Global Alzheimer's Platform Foundation (GAP), and Alzheimer's Disease (AD) Data Initiative.

Purpose of the Study:

  • To create a truly open data resource for Alzheimer's Disease (AD) research.
  • To facilitate innovation and collaboration among researchers worldwide.
  • To lower administrative burdens for accessing and utilizing research data.

Main Methods:

  • Utilized the GAP BioHermes dataset with clinical, demographic, and biomarker data from over 1000 participants.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702
  • Hosted the BioHermes IPD on the AD Data Initiative's AD Workbench for broad accessibility.
  • Implemented robust ethics and data governance while offering end-to-end research support.

    • Main Results:

    • Over 40 international teams and 100 researchers accessed the data resource.
    • Active projects investigate frailty, cognitive reserve, and cardiovascular risk factors in dementia.
    • Results will be shared at a research showcase in March 2025.

    Conclusions:

    • The initiative successfully facilitated innovation and collaboration through easy-access, open data.
    • The quality and volume of early results demonstrate the potential of open data models.
    • The project serves as a potential model for future data sharing initiatives in dementia research.